NRX Pharmaceuticals

Price & Volume

Stats

52W Range	$1.10-$6.01
Market Cap	$35.1M
Shares Short	1M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$2.37

News

Yahoo Finance • 2 years ago

STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of NRx Pharmaceuticals, Inc. and Encourages Long-Term NRXP / BRPA Investors to Contact the Firm

About

CEO	Dr. Jonathan C. Javitt M.D., M.P.H.
Address	1201 Orange Street, Wilmington, DE, United States, 19801
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	0